DocDollars

Bioxcel Therapeutics, Inc.

CT · United States · Reporting entity ID 100001326931

Total reported 2019–2025
$15.0M
#391 of 2,960 reporting companies — 0% of all reported industry payments
$1.18M in general payments across 5,287 records, plus $13.8M in research funding across 369 records.

How it breaks down

General payments $1,177,251
Research funding $13,825,114

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Bioxcel Therapeutics, Inc. reported $15.0M to US doctors and teaching hospitals from 2019 to 2025, ranking #391 of 2,960 reporting companies. 92% of that was research funding and 8% general payments such as consulting, speaking, food and travel. 5,287 general payment records and 369 research records were filed.

Common questions about Bioxcel Therapeutics, Inc.

How much has Bioxcel Therapeutics, Inc. paid US doctors?

Bioxcel Therapeutics, Inc. reported $15,002,365 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $1,177,251 in general payments, $13,825,114 in research funding.

How does Bioxcel Therapeutics, Inc. rank among drug and device companies?

It ranks #391 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Bioxcel Therapeutics, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.